Diversity, classification and evolution of CRISPR-Cas systems
Open accessAbstract
The bacterial and archaeal CRISPR-Cas systems of adaptive immunity show remarkable diversity of protein composition, effector complex structure, genome locus architecture and mechanisms of adaptation, pre-CRISPR (cr)RNA processing and interference. The CRISPR-Cas systems belong to two classes, with multi-subunit effector complexes in Class 1 and single-protein effector modules in Class 2. Concerted genomic and experimental efforts on comprehensive characterization of Class 2 CRISPR-Cas systems led to the identification of two new types and several subtypes. The newly characterized type VI systems are the first among the CRISPR-Cas variants to exclusively target RNA. Unexpectedly, in some of the class 2 systems, the effector protein is additionally responsible for the pre-crRNA processing. Comparative analysis of the effector complexes indicates that Class 2 systems evolved from mobile genetic elements on multiple, independent occasions.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Organisms possessing CRISPR-Cas systems can identify and degrade foreign DNA.
“Therefore, organisms possessing CRISPR-Cas systems can identify and degrade foreign DNA.”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Koonin et al., 2017
CRISPR-Cas is an adaptive immunity system that confers immune memory stored in the form of spacer sequences derived from foreign DNA inserted into the leader-repeat junction.
“CRISPR-Cas (that stand for Clustered Regularly Interspaced Short Palindromic Repeats and CRISPR-associated proteins) is an adaptive immunity system that confers immune memory stored in the form of spacer sequences derived from foreign DNA inserted into the leaderrepeat junction (Garrett et al., 2011; Koonin et al., 2017).”
From Characterization of Limnospira platensis PCC 9108 R-M and CRISPR-Cas systems (2024) · cites this paper as Koonin et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116 · see citing works
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., John van der, O. O. S. T., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,750 · see citing works
Self-citationGasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769 · see citing works
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,512 · see citing works
Self-citationAn updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,504 · see citing works
Self-citationC2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Станиславович, М. Л., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,328 · see citing works
Self-citationCrystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306 · see citing works
Self-citationStructures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230 · see citing works
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Станиславович, М. Л., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,221 · see citing works
Self-citationTwo distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
East-Seletsky, A., O’Connell, M. R., Knight, S. C., Burstein, D. E., Cate, J. H. D., Tjian, R., & Doudna, J. A. (2016) · Nature · doi:10.1038/nature19802 · Cited by 1,180 · see citing works
Diversity and evolution of class 2 CRISPR–Cas systems
Shmakov, S., Smargon, A. A., Scott, D. A., Cox, D. B. T., Pyzocha, N., Yan, W. X., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,056 · see citing works
Self-citationCRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2016) · Cell · doi:10.1016/j.cell.2016.10.044 · Cited by 1,011 · see citing works
Biology and Applications of CRISPR Systems: Harnessing Nature’s Toolbox for Genome Engineering
Wright, A. V., Nuñez, J. K., & Doudna, J. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.035 · Cited by 1,001 · see citing works
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
Fonfara, I., Richter, H., Bratovič, M., Rhun, A. L., & Charpentier, E. (2016) · Nature · doi:10.1038/nature17945 · Cited by 976 · see citing works
Multiplex gene editing by CRISPR–Cpf1 using a single crRNA array
Zetsche, B., Heidenreich, M., Mohanraju, P., Fedorova, I., Kneppers, J., DeGennaro, E. M., Winblad, N., Choudhury, S. R., Abudayyeh, O. O., Gootenberg, J. S., et al. (2017) · Nature Biotechnology · doi:10.1038/nbt.3737 · Cited by 926 · see citing works
Self-citationBacteriophage genes that inactivate the CRISPR/Cas bacterial immune system
Bondy-Denomy, J., Pawluk, A., Maxwell, K. L., & Davidson, A. R. (2012) · Nature · doi:10.1038/nature11723 · Cited by 818 · see citing works
Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
Yamano, T., Nishimasu, H., Zetsche, B., Hirano, H., Slaymaker, I. M., Li, Y., Fedorova, I., Nakane, T., Makarova, K. S., Koonin, E. V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.003 · Cited by 756 · see citing works
Self-citationUnravelling the structural and mechanistic basis of CRISPR–Cas systems
John van der, O. O. S. T., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 715 · see citing works
CRISPR-mediated adaptive immune systems in bacteria and archaea
Sorek, R., Lawrence, C. M., & Wiedenheft, B. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-072911-172315 · Cited by 668 · see citing works
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & John van der, O. O. S. T. (2016) · Science · doi:10.1126/science.aad5147 · Cited by 668 · see citing works
Self-citationStructures of a CRISPR-Cas9 R-loop complex primed for DNA cleavage
Jiang, F., Taylor, D. W., Chen, J. S., Kornfeld, J. E., Zhou, K., Thompson, A. J., Nogales, E., & Doudna, J. A. (2016) · Science · doi:10.1126/science.aad8282 · Cited by 616 · see citing works
Structural Basis for Guide RNA Processing and Seed-Dependent DNA Targeting by CRISPR-Cas12a
Swarts, D. C., John van der, O. O. S. T., & Jínek, M. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.03.016 · Cited by 615 · see citing works
Smargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.023 · Cited by 575 · see citing works
Self-citationNew CRISPR–Cas systems from uncultivated microbes
Burstein, D. E., Harrington, L. B., Strutt, S. C., Probst, A. J., Anantharaman, K., Thomas, B. C., Doudna, J. A., & Banfield, J. F. (2016) · Nature · doi:10.1038/nature21059 · Cited by 574 · see citing works
The evolutionary journey of Argonaute proteins
Swarts, D. C., Makarova, K. S., Wang, Y., Nakanishi, K., Ketting, R. F., Koonin, E. V., Patel, D. J., & John van der, O. O. S. T. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2879 · Cited by 547 · see citing works
Self-citationClassification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498 · see citing works
Self-citationMakarova, K. S., Aravind, L., Wolf, Y. I., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-38 · Cited by 470 · see citing works
Self-citationCrystal Structure of Staphylococcus aureus Cas9
Nishimasu, H., Cong, L., Yan, W. X., Ran, F. A., Zetsche, B., Li, Y., Kurabayashi, A., Ishitani, R., Zhang, F., & Nureki, O. (2015) · Cell · doi:10.1016/j.cell.2015.08.007 · Cited by 430 · see citing works
Self-citationThe crystal structure of Cpf1 in complex with CRISPR RNA
Dong, D., Ren, K., Qiu, X., Zheng, J., Guo, M., Guan, X., Liu, H., Li, N., Zhang, B., Yang, D.-J., et al. (2016) · Nature · doi:10.1038/nature17944 · Cited by 413 · see citing works
CRISPR–Cas adaptation: insights into the mechanism of action
Amitai, G., & Sorek, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.14 · Cited by 411 · see citing works
Co-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity
Samai, P., Pyenson, N. C., Jiang, W., Goldberg, G. W., Hatoum-Aslan, A., & Marraffini, L. A. (2015) · Cell · doi:10.1016/j.cell.2015.04.027 · Cited by 402 · see citing works
Naturally Occurring Off-Switches for CRISPR-Cas9
Pawluk, A., Amrani, N., Zhang, Y., Garcı́a, B., Hidalgo-Reyes, Y., Lee, J., Edraki, A., Shah, M. K., Sontheimer, E. J., Maxwell, K. L., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.017 · Cited by 384 · see citing works
Structure and Engineering of Francisella novicida Cas9
Hirano, H., Gootenberg, J. S., Horii, T., Abudayyeh, O. O., Kimura, M., Hsu, P. D., Nakane, T., Ishitani, R., Hatada, I., Zhang, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.01.039 · Cited by 361 · see citing works
Self-citationMultiple mechanisms for CRISPR–Cas inhibition by anti-CRISPR proteins
Bondy‐Denomy, J., Garcı́a, B., Strum, S. W., Du, M., Rollins, M. F., Hidalgo-Reyes, Y., Wiedenheft, B., Maxwell, K. L., & Davidson, A. R. (2015) · Nature · doi:10.1038/nature15254 · Cited by 356 · see citing works
Two Distant Catalytic Sites Are Responsible for C2c2 RNase Activities
Liu, L., Li, X., Wang, J., Wang, M., Chen, P., Yin, M., Li, J., Sheng, G., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2016.12.031 · Cited by 319 · see citing works
Inactivation of CRISPR-Cas systems by anti-CRISPR proteins in diverse bacterial species
Pawluk, A., Staals, R. H. J., Taylor, C., Watson, B. N. J., Saha, S., Fineran, P. C., Maxwell, K. L., & Davidson, A. R. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.85 · Cited by 312 · see citing works
Hale, C. R., Majumdar, S., Elmore, J. R., Pfister, N. T., Compton, M. M., Olson, S., Resch, A. M., Glover, C. V. C., Graveley, B. R., Terns, R. M., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.023 · Cited by 294 · see citing works
Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity
Charpentier, E., Richter, H., John van der, O. O. S. T., & White, M. F. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv023 · Cited by 292 · see citing works
Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis
Zhang, Y., Heidrich, N., Ampattu, B. J., Gunderson, C. W., Seifert, H. S., Schoen, C. U., Vogel, J., & Sontheimer, E. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.001 · Cited by 283 · see citing works
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 278 · see citing works
CRISPR-Based Technologies for the Manipulation of Eukaryotic Genomes
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · Cell · doi:10.1016/j.cell.2017.04.005 · Cited by 276 · see citing works
Type II restriction endonucleases—a historical perspective and more
Pingoud, A. M., Wilson, G. G., & Wende, W. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku447 · Cited by 274 · see citing works
PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease
Yang, H., Gao, P., Rajashankar, K. R., & Patel, D. J. (2016) · Cell · doi:10.1016/j.cell.2016.11.053 · Cited by 272 · see citing works
Anantharaman, V., Makarova, K. S., Burroughs, A. M., Koonin, E. V., & Aravind, L. (2013) · Biology Direct · doi:10.1186/1745-6150-8-15 · Cited by 263 · see citing works
Self-citationCrystal structure of the CRISPR RNA–guided surveillance complex from Escherichia coli
Jackson, R. N., Golden, S. M., van Erp, P. B. G., Carter, J. J., Westra, E. R., Brouns, S. J. J., John van der, O. O. S. T., Terwilliger, T. C., Read, R. J., & Wiedenheft, B. (2014) · Science · doi:10.1126/science.1256328 · Cited by 245 · see citing works
Gao, P., Yang, H., Rajashankar, K. R., Huang, Z., & Patel, D. J. (2016) · Cell Research · doi:10.1038/cr.2016.88 · Cited by 231 · see citing works
Structure and Activity of the RNA-Targeting Type III-B CRISPR-Cas Complex of Thermus thermophilus
Staals, R. H. J., Agari, Y., Maki-Yonekura, S., Zhu, Y., Taylor, D. W., van Duijn, E., Barendregt, A., Vlot, M., Koehorst, J. J., Sakamoto, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.013 · Cited by 217 · see citing works
Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase–Cas1 fusion protein
Silas, S., Mohr, G., Sidote, D. J., Markham, L. M., Sánchez-Amat, A., Bhaya, D., Lambowitz, A. M., & Fire, A. Z. (2016) · Science · doi:10.1126/science.aad4234 · Cited by 208 · see citing works
CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference
Hochstrasser, M. L., Taylor, D. W., Bhat, P., Guegler, C. K., Sternberg, S. H., Nogales, E., & Doudna, J. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405079111 · Cited by 203 · see citing works
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity
Jiang, W., Samai, P., & Marraffini, L. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.053 · Cited by 198 · see citing works
Krupovìč, M., Makarova, K. S., Forterre, P., Prangishvili, D. A., & Koonin, E. V. (2014) · BMC Biology · doi:10.1186/1741-7007-12-36 · Cited by 187 · see citing works
Self-citationThe basic building blocks and evolution of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130038 · Cited by 185 · see citing works
Self-citationC2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism
Liu, L., Chen, P., Wang, M., Li, X., Wang, J., Yin, M., & Wang, Y. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.040 · Cited by 182 · see citing works
Crystal structure of the RNA-guided immune surveillance Cascade complex in Escherichia coli
Zhao, H., Sheng, G., Wang, J., Wang, M., Bunkòczi, G., Gong, W., Wei, Z., & Wang, Y. (2014) · Nature · doi:10.1038/nature13733 · Cited by 176 · see citing works
Evolution of adaptive immunity from transposable elements combined with innate immune systems
Koonin, E. V., & Krupovìč, M. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3859 · Cited by 176 · see citing works
Self-citationMakarova, K. S., Anantharaman, V., Aravind, L., & Koonin, E. V. (2012) · Biology Direct · doi:10.1186/1745-6150-7-40 · Cited by 127 · see citing works
Self-citationStructural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6
Niewoehner, O., & Jínek, M. (2016) · RNA · doi:10.1261/rna.054098.115 · Cited by 127 · see citing works
ISC, a Novel Group of Bacterial and Archaeal DNA Transposons That Encode Cas9 Homologs
Kapitonov, V. V., Makarova, K. S., & Koonin, E. V. (2015) · Journal of Bacteriology · doi:10.1128/jb.00783-15 · Cited by 117 · see citing works
Self-citationHatoum-Aslan, A., Samai, P., Maniv, I., Jiang, W., & Marraffini, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499244 · Cited by 116 · see citing works
Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complexPreprint
Hale, C. R., Cocozaki, A. I., Li, H., Terns, R. M., & Terns, M. P. (2014) · Genes & Development · doi:10.1101/gad.250712.114 · Cited by 111 · see citing works
Nature and Intensity of Selection Pressure on CRISPR-Associated Genes
Takeuchi, N., Wolf, Y. I., Makarova, K. S., & Koonin, E. V. (2011) · Journal of Bacteriology · doi:10.1128/jb.06521-11 · Cited by 102 · see citing works
Self-citationCasposons: mobile genetic elements that gave rise to the CRISPR-Cas adaptation machinery
Krupovìč, M., Béguin, P., & Koonin, E. V. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.04.004 · Cited by 102 · see citing works
Self-citationCoupling immunity and programmed cell suicide in prokaryotes: Life‐or‐death choices
Koonin, E. V., & Zhang, F. (2016) · BioEssays · doi:10.1002/bies.201600186 · Cited by 93 · see citing works
Self-citationA Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses
Jackson, R. N., & Wiedenheft, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.023 · Cited by 86 · see citing works
DNA Targeting by a Minimal CRISPR RNA-Guided Cascade
Hochstrasser, M. L., Taylor, D. W., Kornfeld, J. E., Nogales, E., & Doudna, J. A. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.07.027 · Cited by 81 · see citing works
Krupovìč, M., & Koonin, E. V. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.01.006 · Cited by 80 · see citing works
Self-citationISDra 2 transposition in D einococcus radiodurans is downregulated by TnpB
Pasternak, C., Dulermo, R., Ton‐Hoang, B., Debuchy, R., Siguier, P., Coste, G., Chandler, M., & Sommer, S. (2013) · Molecular Microbiology · doi:10.1111/mmi.12194 · Cited by 57 · see citing works
Hickman, A. B., & Dyda, F. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1180 · Cited by 54 · see citing works
The CRISPR RNA-guided surveillance complex inEscherichia coliaccommodates extended RNA spacers
Luo, M. L., Jackson, R. N., Denny, S. R., Tokmina‐Lukaszewska, M., Maksimchuk, K. R., Lin, W., Bothner, B. B., Wiedenheft, B., & Beisel, C. L. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw421 · Cited by 49 · see citing works
Béguin, P., Charpin, N., Koonin, E. V., Forterre, P., & Krupovìč, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw821 · Cited by 44 · see citing works
Self-citationKuznedelov, K. D., Mekler, V. M., Lemak, S., Tokmina‐Lukaszewska, M., Datsenko, K. A., Jain, I., Savitskaya, E. E., Mallon, J. P., Shmakov, S., Bothner, B. B., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw914 · Cited by 43 · see citing works
Building the Class 2 CRISPR-Cas Arsenal
Lewis, K. M., & Ke, A. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.01.024 · Cited by 32 · see citing works
Type II restriction endonucleases — a historical perspective and more
Pingoud, A. M., Wilson, G. G., & Wende, W. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw513 · Cited by 30 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity
Chen, J. S., Ma, E., Harrington, L. B., Da Costa, M., Tian, X., Palefsky, J. M., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aar6245 · Cited by 4,507 · see citing works
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D. R., Haft, D. H., Horvath, P., et al. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0299-x · Cited by 2,328 · see citing works
Self-citationGenome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
Anzalone, A. V., Koblan, L. W., & Liu, D. R. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0561-9 · Cited by 2,237 · see citing works
The CRISPR tool kit for genome editing and beyond
Adli, M. (2018) · Nature Communications · doi:10.1038/s41467-018-04252-2 · Cited by 1,642 · see citing works
Couvin, D., Bernheim, A. G., Toffano‐Nioche, C., Touchon, M., Michálik, J., Néron, B., Rocha, E. P. C., Vergnaud, G., Gautheret, D., & Pourcel, C. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky425 · Cited by 1,582 · see citing works
CRISPR/Cas Genome Editing and Precision Plant Breeding in Agriculture
Chen, K., Wang, Y., Zhang, R., Zhang, H., & Gao, C. (2019) · Annual Review of Plant Biology · doi:10.1146/annurev-arplant-050718-100049 · Cited by 1,643 · see citing works
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,491 · see citing works
CRISPR-Cas guides the future of genetic engineering
Knott, G. J., & Doudna, J. A. (2018) · Science · doi:10.1126/science.aat5011 · Cited by 1,410 · see citing works
The next generation of CRISPR–Cas technologies and applications
Pickar-Oliver, A., & Gersbach, C. A. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0131-5 · Cited by 1,459 · see citing works
Programmed DNA destruction by miniature CRISPR-Cas14 enzymes
Harrington, L., Burstein, D., Chen, J. S., Páez-Espino, D., Ma, E., Witte, I. P., Cofsky, J. C., Kyrpides, N., Banfield, J., & Doudna, J. (2018) · Science · doi:10.1126/science.aav4294 · Cited by 1,106 · see citing works
DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
Huang, R., & Zhou, P. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0150-x · Cited by 1,231 · see citing works
The Biology of CRISPR-Cas: Backward and Forward
Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018) · Cell · doi:10.1016/j.cell.2017.11.032 · Cited by 1,019 · see citing works
CRISPR/Cas Systems towards Next-Generation Biosensing
Li, Y., Li, S., Wang, J., & Liu, G. (2019) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.12.005 · Cited by 915 · see citing works
The arms race between bacteria and their phage foes
Hampton, H. G., Watson, B. N. J., & Fineran, P. C. (2020) · Nature · doi:10.1038/s41586-019-1894-8 · Cited by 923 · see citing works
Ishino, Y., Krupovìč, M., & Forterre, P. (2018) · Journal of Bacteriology · doi:10.1128/jb.00580-17 · Cited by 558 · see citing works
The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a
Liu, L., Li, X., Ma, J., Li, Z., You, L., Wang, J., Wang, M., Zhang, X., & Wang, Y. (2017) · Cell · doi:10.1016/j.cell.2017.06.050 · Cited by 506 · see citing works
Functionally diverse type V CRISPR-Cas systems
Yan, W. X., Hunnewell, P., Alfonse, L. E., Carte, J. M., Keston-Smith, E., Sothiselvam, S., Garrity, A. J., Chong, S., Makarova, K. S., Koonin, E. V., et al. (2018) · Science · doi:10.1126/science.aav7271 · Cited by 509 · see citing works
Self-citationOrigins and evolution of CRISPR-Cas systems
Koonin, E. V., & Makarova, K. S. (2019) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2018.0087 · Cited by 494 · see citing works
Self-citationSynthetic lethality as an engine for cancer drug target discovery
Huang, A., Garraway, L. A., Ashworth, A., & Weber, B. L. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0046-z · Cited by 470 · see citing works
Type III CRISPR–Cas systems produce cyclic oligoadenylate second messengers
Niewoehner, O., Garcia‐Doval, C., Rostøl, J. T., Berk, C., Schwede, F., Bigler, L., Hall, J., Marraffini, L. A., & Jínek, M. (2017) · Nature · doi:10.1038/nature23467 · Cited by 464 · see citing works
Yan, W. X., Chong, S., Zhang, H., Makarova, K. S., Koonin, E. V., Cheng, D. R., & Scott, D. A. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.028 · Cited by 456 · see citing works
Self-citationCasX enzymes comprise a distinct family of RNA-guided genome editors
Liu, J.-J., Orlova, N., Oakes, B. L., Ma, E., Spinner, H. B., Baney, K. L. M., Chuck, J., Tan, D., Knott, G. J., Harrington, L. B., et al. (2019) · Nature · doi:10.1038/s41586-019-0908-x · Cited by 446 · see citing works
Current understanding of osteoarthritis pathogenesis and relevant new approaches
Tong, L., Yu, H., Huang, X., Shen, J., Xiao, G., Chen, L., Wang, H., Xing, L., & Chen, D. (2022) · Bone Research · doi:10.1038/s41413-022-00226-9 · Cited by 437 · see citing works
Tali, S. H. S., LeBlanc, J. J., Sadiq, Z., Oyewunmi, O. D., Camargo, C., Nikpour, B., Armanfard, N., Sagan, S. M., & Jahanshahi‐Anbuhi, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00228-20 · Cited by 411 · see citing works
Anti-CRISPR: discovery, mechanism and function
Pawluk, A., Davidson, A. R., & Maxwell, K. L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.120 · Cited by 398 · see citing works
Xu, Y., & Li, Z. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.08.031 · Cited by 424 · see citing works
Karvelis, T., Bigelyte, G., Young, J. K., Hou, Z., Žedaveinytė, R., Budre, K., Paulraj, S., Djukanovic, V., Gasior, S. L., Šilanskas, A., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa208 · Cited by 352 · see citing works
Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR–Cas Systems
O’Connell, M. R. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.029 · Cited by 343 · see citing works
Hillary, V. E., & Ceasar, S. A. (2023) · Molecular Biotechnology · doi:10.1007/s12033-022-00567-0 · Cited by 320 · see citing works
CRISPR Ethics: Moral Considerations for Applications of a Powerful Tool
Brokowski, C., & Adli, M. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.05.044 · Cited by 320 · see citing works
Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d
Zhang, C., Konermann, S., Brideau, N. J., Lotfy, P., Wu, X., Novick, S. J., Strutzenberg, T., Griffin, P. R., Hsu, P. D., & Lyumkis, D. (2018) · Cell · doi:10.1016/j.cell.2018.09.001 · Cited by 276 · see citing works
Recruitment of CRISPR-Cas systems by Tn7-like transposons
Peters, J. E., Makarova, K. S., Shmakov, S., & Koonin, E. V. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1709035114 · Cited by 293 · see citing works
Self-citationCRISPR Crops: Plant Genome Editing Toward Disease Resistance
Langner, T., Kamoun, S., & Belhaj, K. (2018) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-050158 · Cited by 290 · see citing works
PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
Gleditzsch, D., Pausch, P., Müller-Esparza, H., Özcan, A., Guo, X., Bange, G., & Randau, L. (2018) · RNA Biology · doi:10.1080/15476286.2018.1504546 · Cited by 281 · see citing works
Discovery of widespread type I and type V CRISPR-Cas inhibitors
Marino, N. D., Zhang, J. Y., Borges, A. L., Sousa, A. A., León, L. M., Rauch, B. J., Walton, R. T., Berry, J. D., Joung, J. K., Kleinstiver, B. P., et al. (2018) · Science · doi:10.1126/science.aau5174 · Cited by 271 · see citing works
CRISPR-Cas based virus detection: Recent advances and perspectives
Yin, L., Man, S., Ye, S., Liu, G., & Ma, L. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113541 · Cited by 281 · see citing works
The genome editing revolution: review
Khalil, A. M. (2020) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-020-00078-y · Cited by 284 · see citing works
CRISPR–Cas in mobile genetic elements: counter-defence and beyond
Faure, G., Shmakov, S., Yan, W. X., Cheng, D. R., Scott, D. A., Peters, J. E., Makarova, K. S., & Koonin, E. V. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0204-7 · Cited by 262 · see citing works
Self-citationClassification and Nomenclature of CRISPR-Cas Systems: Where from Here?
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2018) · The CRISPR Journal · doi:10.1089/crispr.2018.0033 · Cited by 271 · see citing works
Self-citation(Ph)ighting Phages: How Bacteria Resist Their Parasites
Rostøl, J. T., & Marraffini, L. A. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.009 · Cited by 264 · see citing works
Molecular mechanisms of CRISPR–Cas spacer acquisition
McGinn, J., & Marraffini, L. A. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0071-7 · Cited by 257 · see citing works
Challenges and new technologies in adoptive cell therapy
Zhang, P., Zhang, G., & Wan, X. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01492-8 · Cited by 271 · see citing works
Zhang, H., Qin, C., An, C., Zheng, X., Wen, S., Chen, W., Liu, X., Lv, Z., Yang, P., Xu, W., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01431-6 · Cited by 255 · see citing works
Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editing
Swarts, D. C., & Jinek, M. (2018) · WIREs RNA · doi:10.1002/wrna.1481 · Cited by 267 · see citing works
CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point‐of‐Care Diagnosis
Dai, Y., Wu, Y., Liu, G., & Gooding, J. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005398 · Cited by 243 · see citing works
Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
Zhang, D., Hussain, A., Manghwar, H., Xie, K., Xie, S., Zhao, S., Larkin, R. M., Qing, P., Jin, S., & Ding, F. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13383 · Cited by 245 · see citing works
Review of COVID-19 testing and diagnostic methods
Filchakova, O., Dossym, D., Ilyas, A., Kuanysheva, T., Abdizhamil, A., & Bukasov, R. (2022) · Talanta · doi:10.1016/j.talanta.2022.123409 · Cited by 226 · see citing works
CRISPR-based genome editing through the lens of DNA repair
Nambiar, T. S., Baudrier, L., Billon, P., & Ciccia, A. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.026 · Cited by 214 · see citing works
Mechanistic Insights into the cis- and trans-Acting DNase Activities of Cas12a
Swarts, D. C., & Jínek, M. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.11.021 · Cited by 609 · see citing works
Marshall, R., Maxwell, C. S., Collins, S. P., Jacobsen, T., Luo, M. L., Begemann, M. B., Gray, B. N., January, E., Singer, A., He, Y., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2017.12.007 · Cited by 203 · see citing works
The Revolution Continues: Newly Discovered Systems Expand the CRISPR-Cas Toolkit
Murugan, K., Babu, K., Sundaresan, R., Rajan, R., & Sashital, D. G. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.09.007 · Cited by 204 · see citing works
CRISPR–Cas9: A History of Its Discovery and Ethical Considerations of Its Use in Genome Editing
Gostimskaya, I. S. (2022) · Biochemistry (Moscow) · doi:10.1134/s0006297922080090 · Cited by 224 · see citing works
Recent advances in the CRISPR genome editing tool set
Moon, S. B., Kim, D. Y., Ko, J., & Kim, Y.-S. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0339-7 · Cited by 208 · see citing works
Next-Generation Breeding Strategies for Climate-Ready Crops
Razzaq, A., Kaur, P., Akhter, N., Wani, S. H., & Saleem, F. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.620420 · Cited by 209 · see citing works
Lau, R., Ye, Q., Birkholz, E. A., Berg, K. R., Patel, L., Mathews, I. T., Watrous, J. D., Ego, K. M., Whiteley, A. T., Lowey, B., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.12.010 · Cited by 199 · see citing works
Web-based design and analysis tools for CRISPR base editing
Hwang, G.-H., Park, J., Lim, K., Kim, S., Yu, J., Yu, E., Kim, S.-T., Eils, R., Kim, J.-S., & Bae, S. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2585-4 · Cited by 198 · see citing works
Various Aspects of a Gene Editing System—CRISPR–Cas9
Janik, E., Niemcewicz, M., Ceremuga, M., Krzowski, Ł., Saluk, J., & Bijak, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249604 · Cited by 210 · see citing works
CRISPR Cpf1 proteins: structure, function and implications for genome editing
Safari, F., Zare, K., Negahdaripour, M., Barekati‐Mowahed, M., & Ghasemi, Y. (2019) · Cell & Bioscience · doi:10.1186/s13578-019-0298-7 · Cited by 196 · see citing works
Genetically engineered crops for sustainably enhanced food production systems
Aziz, M. A., Brini, F., Rouached, H., & Masmoudi, K. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.1027828 · Cited by 192 · see citing works
Genome editing using the endogenous type I CRISPR-Cas system in Lactobacillus crispatus
Hidalgo-Cantabrana, C., Goh, Y. J., Pan, M., Sanozky-Dawes, R., & Barrangou, R. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1905421116 · Cited by 186 · see citing works
CRISPR/Cas12a-based technology: A powerful tool for biosensing in food safety
Mao, Z., Chen, R., Wang, X., Zixuan, Z., Peng, Y., Li, S., Han, D., Li, S., Wang, Y., Han, T., et al. (2022) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2022.02.030 · Cited by 186 · see citing works
Marine biofilms constitute a bank of hidden microbial diversity and functional potential
Zhang, W., Ding, W., Li, Y., Tam, C., Bougouffa, S., Wang, R., Pei, B., Chiang, H., Leung, P. M., Lu, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08463-z · Cited by 179 · see citing works
Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future
Łobocka, M. B., Dąbrowska, K., & Górski, A. (2021) · BioDrugs · doi:10.1007/s40259-021-00480-z · Cited by 176 · see citing works
CRISPR‐Cas‐based detection for food safety problems: Current status, challenges, and opportunities
Li, Y., Man, S., Ye, S., Liu, G., & Ma, L. (2022) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.13000 · Cited by 175 · see citing works
Synthetic biology and metabolic engineering of actinomycetes for natural product discovery
Palazzotto, E., Tong, Y., Lee, S. Y., & Weber, T. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.005 · Cited by 171 · see citing works
Mobile Genetic Elements and Evolution of CRISPR-Cas Systems: All the Way There and Back
Koonin, E. V., & Makarova, K. S. (2017) · Genome Biology and Evolution · doi:10.1093/gbe/evx192 · Cited by 166 · see citing works
Self-citationGenetic Engineering of Bacteriophages Against Infectious Diseases
Chen, Y., Batra, H., Dong, J., Chen, C., Rao, V. B., & Pan, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00954 · Cited by 168 · see citing works
Anti-CRISPRs: Protein Inhibitors of CRISPR-Cas Systems
Davidson, A. R., Lu, W., Stanley, S. Y., Wang, J., Mejdani, M., Trost, C. N., Hicks, B. T., Lee, J., & Sontheimer, E. J. (2020) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-011420-111224 · Cited by 167 · see citing works
Structures, mechanisms and applications of RNA-centric CRISPR–Cas13
Yang, H., & Patel, D. J. (2024) · Nature Chemical Biology · doi:10.1038/s41589-024-01593-6 · Cited by 173 · see citing works
Pourcel, C., Touchon, M., Villeriot, N., Vernadet, J., Couvin, D., Toffano‐Nioche, C., & Vergnaud, G. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz915 · Cited by 164 · see citing works
Genetic engineering of T cells for immunotherapy
Ellis, G. I., Sheppard, N. C., & Riley, J. L. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-021-00329-9 · Cited by 166 · see citing works
The Central Role of Interbacterial Antagonism in Bacterial Life
Peterson, S. B., Bertolli, S. K., & Mougous, J. D. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.103 · Cited by 162 · see citing works
Shmakov, S., Makarova, K. S., Wolf, Y. I., Severinov, K., & Koonin, E. V. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1803440115 · Cited by 157 · see citing works
Self-citationYang, Y., Liu, J., & Zhou, X. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113418 · Cited by 158 · see citing works
CRISPR-Cas9/Cas12a biotechnology and application in bacteria
Yao, R., Liu, D., Jia, X., Zheng, Y., Liu, W. Y., & Xiao, Y. (2018) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2018.09.004 · Cited by 159 · see citing works
Current Status and Challenges of DNA Base Editing Tools
Jeong, Y. K., Song, B., & Bae, S. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.07.021 · Cited by 153 · see citing works
Dong, W., & Kantor, B. (2021) · Viruses · doi:10.3390/v13071288 · Cited by 153 · see citing works
Rostøl, J. T., & Marraffini, L. A. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0353-x · Cited by 148 · see citing works
Type II-C CRISPR-Cas9 Biology, Mechanism, and Application
Mir, A., Edraki, A., Lee, J., & Sontheimer, E. J. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00855 · Cited by 148 · see citing works
CRISPR-Cas Biology and Its Application to Infectious Diseases
Strich, J. R., & Chertow, D. S. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01307-18 · Cited by 148 · see citing works
Barriers to genome editing with CRISPR in bacteria
Vento, J. M., Crook, N., & Beisel, C. L. (2019) · Journal of Industrial Microbiology & Biotechnology · doi:10.1007/s10295-019-02195-1 · Cited by 136 · see citing works
Phage-Encoded Anti-CRISPR Defenses
Stanley, S. Y., & Maxwell, K. L. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031321 · Cited by 142 · see citing works
CRISPR/Cas-powered nanobiosensors for diagnostics
Phan, Q. A., Truong, L. B., Medina-Cruz, D., Dincer, C., & Mostafavi, E. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113732 · Cited by 142 · see citing works
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi
Bendixen, L., Jensen, T. I., & Bak, R. O. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.03.024 · Cited by 144 · see citing works
Zheng, Y., Han, J., Liang, W., Li, R., Hu, X., Wang, B., shen, W., Ma, L., Ma, L., Yi, L., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz940 · Cited by 141 · see citing works
Signal amplification and output of CRISPR/Cas-based biosensing systems: A review
Wang, S.-Y., Du, Y., Wang, D., Ma, J.-Y., Tang, A., & Kong, D. (2021) · Analytica Chimica Acta · doi:10.1016/j.aca.2021.338882 · Cited by 140 · see citing works
The chemistry of Cas9 and its CRISPR colleagues
Chen, J. S., & Doudna, J. A. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0078 · Cited by 139 · see citing works
Diverse virus-encoded CRISPR-Cas systems include streamlined genome editors
Al-Shayeb, B., Skopintsev, P., Soczek, K. M., Stahl, E. C., Li, Z., Groover, E. D., Smock, D. C. J., Eggers, A. R., Pausch, P., Cress, B. F., et al. (2022) · Cell · doi:10.1016/j.cell.2022.10.020 · Cited by 139 · see citing works
Anti-CRISPR proteins encoded by archaeal lytic viruses inhibit subtype I-D immunity
He, F., Bhoobalan-Chitty, Y., van Eck, L., Kjeldsen, A. L., Dedola, M., Makarova, K. S., Koonin, E. V., Brodersen, D. E., & Peng, X. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0120-z · Cited by 137 · see citing works
Self-citationCRISPR-Based Diagnosis of Infectious and Noninfectious Diseases
vangah, S. J., Katalani, C., Boone, H. A., Hajizade, A., Sijerčić, A., & Ahmadian, G. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00135-3 · Cited by 137 · see citing works
A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
Razeghian, E., Nasution, M. K. M., Rahman, H. S., Gardanova, Z. R., Abdelbasset, W. K., Surendar, A., Bokov, D. O., Suksatan, W., Nakhaei, P., Shariatzadeh, S., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02510-7 · Cited by 145 · see citing works
CRISPR RNA-Dependent Binding and Cleavage of Endogenous RNAs by the Campylobacter jejuni Cas9
Dugar, G., Leenay, R. T., Eisenbart, S. K., Bischler, T., Aul, B. U., Beisel, C. L., & Sharma, C. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.032 · Cited by 136 · see citing works
An Outlook on Global Regulatory Landscape for Genome-Edited Crops
Ahmad, A., Munawar, N., Khan, Z., Qumsani, A. T., Khan, S. H., Jamil, A., Ashraf, S., Ghouri, M. Z., Aslam, S., Mubarik, M. S., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111753 · Cited by 137 · see citing works
Kumlehn, J., Pietralla, J., Hensel, G., Pacher, M., & Puchta, H. (2018) · Journal of Integrative Plant Biology · doi:10.1111/jipb.12734 · Cited by 134 · see citing works
CRISPR/Cas-based genome engineering in natural product discovery
Tong, Y., Weber, T., & Lee, S. Y. (2018) · Natural Product Reports · doi:10.1039/c8np00089a · Cited by 130 · see citing works
Schmid‐Hempel, P. (2021) · doi:10.1093/oso/9780198832140.001.0001 · Cited by 130 · see citing works
Editing the microbiome the CRISPR way
Ramachandran, G., & Bikard, D. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0103 · Cited by 127 · see citing works
Versatile detection with CRISPR/Cas system from applications to challenges
Wu, H., Chen, X., Zhang, M., Wang, X., Chen, Y., Qian, C., Wu, J. F., & Xu, J. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116150 · Cited by 130 · see citing works
Advances in CRISPR-Cas systems for RNA targeting, tracking and editing
Wang, F., Wang, L., Zou, X., Duan, S., Li, Z., Deng, Z., Luo, J., Lee, S. Y., & Chen, S. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.03.016 · Cited by 128 · see citing works
Nalefski, E. A., Patel, N. V., Leung, P. J. Y., Islam, Z., Kooistra, R. M., Parikh, I., Marion, E., Knott, G. J., Doudna, J. A., Ny, A.-L. M. L., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102996 · Cited by 127 · see citing works
- Authors
- Koonin, E. V., Makarova, K. S., & Zhang, F.
- Affiliations
- United States National Library of Medicine (US)
- Broad Institute (US)
- Corresponding author
- Koonin, Eugene V
- Venue
- Current Opinion in Microbiology
- Publisher
- Elsevier BV
- Published
- 2017-06
- Volume
- 37
- Pages
- 67-78
- ISSN
- 1369-5274 (ISSN-L)
- PMC
- PMC5776717
- OpenAlex
- W2623277795
- Cited by
- 1,423
- References
- 73
- Citations by year
- 2026: 70 · 2025: 139 · 2024: 157 · 2023: 136 · 2022: 184 · 2021: 191 · 2020: 178 · 2019: 206 · 2018: 127 · 2017: 33 · 2013: 1
- FWCI
- 13.98
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current Opinion in Microbiology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institutes of Health
- U.S. National Library of Medicine (Z01LM000073)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Keywords
- CRISPR-Cas, adaptive immunity, mobile genetic elements, CRISPR adaptation, comparative genomics
- MeSH terms
- Archaea, Bacteria, Genetic Variation, Evolution, Molecular, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
